• Explore /
  • Poster
  • / Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40).

Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40).

Abstract Poster

Authors

Gunter Von Minckwitz

G. Von Minckwitz

German Breast Group, Neu-Isenburg, Germany

G. Von Minckwitz , S. Darb-Esfahani , S. Loibl , J. B. Huober , H. Tesch , C. Solbach , F. Holms , H. Eidtmann , K. Diedrich , M. Just , M. Clemens , C. Hanusch , I. Schrader , S. Henschen , G. Hoffmann , K. Tiemann , K. Diebold , M. Untch , C. Denkert

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 Breast Cancer Symposium

Session Type

Poster Discussion Session

Session Title

Poster Discussion A

Track

Detection, Screening, and Imaging,Local/Regional Therapy

Sub Track

Predictive and Prognostic Factors

Clinical Trial Registration Number

NCT 00288002

Citation

J Clin Oncol 29, 2011 (suppl 27; abstr 6)

Abstract #

6

Poster Bd #

A4

Abstract Disclosures

Similar Posters

First Author: Tarek Mohamed Ahmed Abdel-Fatah

First Author: Takashi Ishikawa

First Author: Jenny Furlanetto

First Author: Christian Eichler